Your browser doesn't support javascript.
loading
Safety and efficacy of classical complement pathway inhibition with sutimlimab in chronic immune thrombocytopenia.
Broome, Catherine M; Röth, Alexander; Kuter, David J; Scully, Marie; Smith, Roy; Wang, Jennifer; Reuter, Caroline; Hobbs, William; Daak, Ahmed.
Afiliação
  • Broome CM; Division of Hematology, MedStar Georgetown University Hospital, Washington, DC.
  • Röth A; Department of Hematology and Stem Cell Transplantation, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
  • Kuter DJ; Division of Hematology, Massachusetts General Hospital, Harvard Medical School, Boston, MA.
  • Scully M; Department of Haematology, University College London Hospitals, Cardiometabolic Program, National Institute for Health Research UCLH/UCL Biomedical Research Centre, London, United Kingdom.
  • Smith R; Division of Hematology/Oncology, University of Pittsburgh Medical Center, Pittsburgh, PA.
  • Wang J; Sanofi, Cambridge, MA.
  • Reuter C; Sanofi, Cambridge, MA.
  • Hobbs W; Sanofi, Cambridge, MA.
  • Daak A; Sanofi, Cambridge, MA.
Blood Adv ; 7(6): 987-996, 2023 03 28.
Article em En | MEDLINE | ID: mdl-35973190
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Púrpura Trombocitopênica Idiopática Limite: Adult / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Púrpura Trombocitopênica Idiopática Limite: Adult / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article